With a $62,000 grant from FRAXA Research Foundation from 1999-2000, Dr. Giovanni Neri and his team at Universita Cattolica del S. Cuore explored possible strategies to turn the Fragile X gene back on.
Read moreFRAXA Research Grants
As the pace of Fragile X research accelerates, FRAXA research teams are leading the way.
The research we fund spans the spectrum of basic science, pre-clinical, and clinical research — all coordinated to make the most of each dollar. We develop many treatment strategies in parallel, since success is never certain when developing a drug. We continue to fund research to define the precise defect in the Fragile X brain, because these studies may yield additional important treatment targets.
Imaging of Neocortical Dendritic Spine Maturation in FMR1 Knockout Mice Using Two-Photon Laser Scanning Microscopy
With $30,000 in funding from FRAXA Research Foundation in 1999, Dr. Karel Svoboda and his team at the Cold Spring Harbor Laboratory explored the changing nature of dendritic spine motility by imaging neocortical circuits in Fragile X mice.
Read morePsychophysiological Measures of Arousal: Documentation of Treatment Effects & Impact of Disability
With a $60,000 grant from FRAXA Research Foundation from 1998-2000, Dr. Don Bailey and his team at the University of North Carolina explored the role of arousal in individuals that are affected by Fragile X syndrome.
Read moreImproving Memory Reversal Testing and Treatment with AMPAkines in the Fragile X Knock-Out Mouse
A two year $62,000 FRAXA grant was been awarded to W. Ted Brown, MD, PhD from 1997-1998. The Principal Investigator at the Institute For Basic Research in New York aims to develop an improved test to show learning deficits in the FMR1 knock-out mouse model of Fragile X, and test experimental drugs (Ampakines) that may be effective in treating these deficits.
Read more